# A Study of Gimatecan (ST1481) in Small Cell Lung Cancer

> **NCT04501029** · PHASE2 · UNKNOWN · sponsor: **Lee's Pharmaceutical Limited** · enrollment: 70 (estimated)

## Conditions studied

- Small Cell Lung Cancer

## Interventions

- **DRUG:** Gimatecan

## Key facts

- **NCT ID:** NCT04501029
- **Lead sponsor:** Lee's Pharmaceutical Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-10-01
- **Primary completion:** 2022-10-01
- **Final completion:** 2023-10-01
- **Target enrollment:** 70 (ESTIMATED)
- **Last updated:** 2020-08-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04501029

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04501029, "A Study of Gimatecan (ST1481) in Small Cell Lung Cancer". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT04501029. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*